Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Michel-Olivier Gratton"'
Autor:
Adi J. Klil-Drori, Hui Yin, Laurent Azoulay, Michaël Harnois, Michel-Olivier Gratton, Lambert Busque, Sarit E. Assouline
Publikováno v:
Haematologica, Vol 104, Iss 7 (2019)
Externí odkaz:
https://doaj.org/article/2a2ce2466efd412eae2c44ee54ee3d63
Autor:
Lambert Busque, Kevin Simpson-Poirier, Michel-Olivier Gratton, Robert Delage, Luigina Mollica, Harold J. Olney, Shireen Sirhan, Pierre Laneuville, Michaël Harnois, Sarit Assouline, Natasha Szuber
Publikováno v:
American Journal of Hematology. 96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53679a6b61979f5abf0484ece1b4df38
https://doi.org/10.1002/ajh.26159
https://doi.org/10.1002/ajh.26159
Autor:
Pierre Laneuville, Hui Yin, Laurent Azoulay, Michaël Harnois, Robert Delage, Lambert Busque, Harold J. Olney, Luigina Mollica, Alexa Del Corpo, Michel-Olivier Gratton, Sarit Assouline, Adi J. Klil-Drori
Publikováno v:
Cancer. 125(4)
BACKGROUND In the current study, the authors determined whether adhering to molecular monitoring guidelines in patients with chronic myeloid leukemia (CML) is associated with major molecular response (MMR) and assessed barriers to adherent monitoring
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9388d752d20b44b745e300975c3eff5
https://pubmed.ncbi.nlm.nih.gov/30423211
https://pubmed.ncbi.nlm.nih.gov/30423211
Autor:
Adi J. Klil-Drori, Sarit Assouline, Alexa Del Corpo, Harold J. Olney, Hui Yin, Lambert Busque, Michel-Olivier Gratton, Luigina Mollica, Pierre Laneuville, Michaël Harnois, Robert Delage, Laurent Azoulay
Publikováno v:
American Journal of Hematology. 92
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b23d7f0c4229bc5a66b1be15d2c627dd
https://doi.org/10.1002/ajh.24838
https://doi.org/10.1002/ajh.24838
Autor:
Alexa Del Corpo, Harold J. Olney, Adi J. Klil-Drori, Hui Yin, Lambert Busque, Michel-Olivier Gratton, Sarit Assouline, Michaël Harnois, Robert Delage, Luigina Mollica, Pierre Laneuville, Laurent Azoulay, Ines Chamakhi
Publikováno v:
Blood. 128:3072-3072
Background: Timely molecular monitoring is the cornerstone of chronic myeloid leukemia (CML) treatment guidelines. These guidelines are based on the design of clinical trials, but none have been validated prospectively. We hypothesized that timely mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf8fd14c2003f15fc7e8443afdb65564
https://doi.org/10.1182/blood.v128.22.3072.3072
https://doi.org/10.1182/blood.v128.22.3072.3072
Autor:
Xavier Billot, Michel-Olivier Gratton, Manon Lavoie, Michael Lawless, Kenza Dairi, Gordon C. Shore, Cynthia Bernier, Mai Nguyen, Anne Roulston, Pierre Beauparlant, Karine Gilbert, Helen M. Chan, Henady Isakau, Daniel Goulet, Denis Paquette, Abdelkrim Khadir, Alvin Berger, Richard C. Marcellus, Dominique Bédard, Anne Jang, Emilie Turcotte, Laurent Bélec, Stephane Branchaud, Elizabeth Koch, Matthew W. Mitchell, Mark F. Watson
GMX1777 is a prodrug of the small molecule GMX1778, currently in phase I clinical trials for the treatment of cancer. We describe findings indicating that GMX1778 is a potent and specific inhibitor of the NAD(+) biosynthesis enzyme nicotinamide phosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70b8a3de94442e61e49a10ce45e1a472
https://europepmc.org/articles/PMC2772749/
https://europepmc.org/articles/PMC2772749/
Autor:
Harold J. Olney, Adi J. Klil-Drori, Pierre Laneuville, Michaël Harnois, Ines Chamakhi, Laurent Azoulay, Michel-Olivier Gratton, Sarit Assouline, Lambert Busque, Luigina Mollica, Hui Yin, Robert Delage
Publikováno v:
Blood. 126:2778-2778
Background: Generic versions of imatinib (GEN) have been approved for use in Canada for chronic myeloid leukemia, chronic phase (CML-CP) on the basis of bioequivalence studies and were reimbursed in Québec starting from October 2013. Molecular respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5adaf3748ee92ba4ee46e526db6f224b
https://doi.org/10.1182/blood.v126.23.2778.2778
https://doi.org/10.1182/blood.v126.23.2778.2778
Autor:
Elena Torban, Stephanie Belanger Jasmin, Michael S. German, Francesca M. Theriault, Michel-Olivier Gratton, Stefano Stifani
Hes1 is a mammalian basic helix-loop-helix transcriptional repressor that inhibits neuronal differentiation together with corepressors of the Groucho (Gro)/Transducin-like Enhancer of split (TLE) family. The interaction of Hes1 with Gro/TLE is mediat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85c84c3629e5847c21b537baef9f1cd2
https://europepmc.org/articles/PMC193938/
https://europepmc.org/articles/PMC193938/